EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
- PMID: 19838704
- DOI: 10.1007/s00259-009-1265-z
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
Abstract
The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice.The present document is an update of the first guidelines for SPECT using D2 receptor ligands labelled with (123)I [1] and was guided by the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines intend to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.
Similar articles
-
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):443-50. doi: 10.1007/s00259-009-1267-x. Eur J Nucl Med Mol Imaging. 2010. PMID: 19838702
-
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2093-102. doi: 10.1007/s00259-009-1266-y. Eur J Nucl Med Mol Imaging. 2009. PMID: 19838703
-
European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):BP23-9. Eur J Nucl Med Mol Imaging. 2002. PMID: 12436495 No abstract available.
-
Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.J Cereb Blood Flow Metab. 2000 Mar;20(3):423-51. doi: 10.1097/00004647-200003000-00001. J Cereb Blood Flow Metab. 2000. PMID: 10724107 Review.
-
Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.Nucl Med Rev Cent East Eur. 2006;9(2):147-53. Nucl Med Rev Cent East Eur. 2006. PMID: 17304479 Review.
Cited by
-
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study.Life (Basel). 2023 Aug 21;13(8):1786. doi: 10.3390/life13081786. Life (Basel). 2023. PMID: 37629643 Free PMC article.
-
Amyloid pathology induces dysfunction of systemic neurotransmission in aged APPswe/PS2 mice.Front Neurosci. 2022 Aug 5;16:930613. doi: 10.3389/fnins.2022.930613. eCollection 2022. Front Neurosci. 2022. PMID: 35992913 Free PMC article.
-
Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast-Developing Field.Ann Neurol. 2021 Nov;90(5):711-719. doi: 10.1002/ana.26187. Epub 2021 Aug 27. Ann Neurol. 2021. PMID: 34338333 Free PMC article. Review.
-
Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.Turk J Med Sci. 2021 Apr 30;51(2):400-410. doi: 10.3906/sag-2008-253. Turk J Med Sci. 2021. PMID: 33237660 Free PMC article. Review.
-
Faster Acquisition for Dopamine Transporter Imaging Using Swiftscan Step and Shoot Continuous SPECT Without Impairing Visual and Semiquantitative Analysis.Front Med (Lausanne). 2020 Jun 18;7:235. doi: 10.3389/fmed.2020.00235. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32626716 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources